US Patent Issued to Epitracker on Oct. 14 for "Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain" (California Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,473, issued on Oct. 14, was assigned to Epitracker Inc. (San Diego).

"Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain" was invented by Stephanie Venn-Watson (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions comprising fatty acid analogs are provided for treating conditions involving impaired cognition, movement disorders, chronic pain, depression, decreased appetite, addiction, seizure, and convulsion, and other conditions. Methods for the diagnosis and monitoring of impaired cognition, movement disorders, chronic pain, depression, decreased appetite, addiction, ...